Proactive therapeutic drug monitoring is not associated with lower rates of steroid exposure or excess in adalimumab treated IBD patients

GUT(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要